← Cockpit
248_029predictionBiotech/LongevityAI-timing

Regime change at the FDA is not beyond the realm of reason.

Predictor: Alex Wissner-Gross · ep#248 "Sam Altman's Attack, Amazon vs. Starlink, and What Opus 4.7 Actually Means | #248" · source

Prior probability
40.0%
Current probability
34.9%
evolves via intake + LBP
Conviction
2/5
Signal quality
C
Resolution
pending
Window
2026-06-01 – 2026-06-30
Edges in / out
8 / 5
Tickers exposed
34

Prediction text

Regime change at the FDA is not beyond the realm of reason. | we're going to see this type of story I think more and more frequently until some sort of regime change at the FDA which also is not beyond the realm of reason.

Verbatim quote

From episode "Sam Altman's Attack, Amazon vs. Starlink, and What Opus 4.7 Actually Means | #248"
we're going to see this type of story I think more and more frequently until some sort of regime change at the FDA which also is not beyond the realm of reason.

Predictor: Alex Wissner-Gross

κ + Brier as of 2026-05-22
κ (discount)
0.844
Brier
0.0341
excellent
Hits / Misses
6 / 1
of 11 resolved
Hit rate
54.5%
Calibration plot (stated vs observed)

Evidence about this node from Alex Wissner-Gross is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).

Reference class: fda_breakthrough_label

Linked via embedding similarity 0.560

FDA breakthrough designation → approval within 4 years

Base rate
39.0%
78/200 historical
Inside weight
0.395
TRF=0.86
Outside weight
0.605
pulling toward base rate
inside 29.0% → blend 34.9% 5.9pp)

Tetlock-style outside view: at TRF=1 (just predicted), outside view dominates (w_in=0.3). At TRF=0 (deadline), inside view dominates (w_in=1.0). The blend regularizes overconfident inside views toward the historical base rate.

Probability over time

7 prob_history rows
0%25%50%75%100%prior 40%2026-04-302026-04-302026-06-04
intake v2milestone miss sweeplbp propagationreference class assignedlegacy v1prior_prob (analyst seed)current = 34.9%

Milestone chain

Pre-event signals (upstream prereqs + window checkpoints) → resolution event → downstream cascades. Status/dates update from linked nodes; re-derive nightly via scripts/ops/derive_milestones.py.
Leading chain: 5 fired ✓ · 2 overdue ⏱
  1. 2026-05-01 → 2026-06-22overdueFDA Commissioner Makary departure, replacement, or announced leave
    How: HHS or White House announces resignation, removal, or extended leave of FDA Commissioner Marty Makary
    Source: BioPharma Dive turnover reporting; InsideHealthPolicyconf 20%
  2. 2026-05-01 → 2026-06-22overdueRFK Jr override of FDA decision becomes public or formal
    How: HHS Secretary Kennedy publicly reverses or directs FDA decision in writing, contradicting Makary public stance
    Source: BioSpace; Boston Globe Apr 23 2026conf 50%
  3. 2026-05-01 → 2026-09-30pendingMajor FDA reorganization or RIF (reduction in force) announcement
    How: Federal Register or HHS announcement of FDA org-chart restructure, large-scale layoffs, or center consolidation
    Source: InsideHealthPolicy; NBC News RFK Jr changesconf 40%
  4. 2026-05-01 → 2026-12-31pendingCongressional hearing or bipartisan letter calls for FDA reform
    How: Senate HELP or House E&C committee schedules hearing or issues formal letter on FDA leadership/integrity post Sarepta and cancer-drug rejections
    Source: newrepublic Sarepta/cancer-drug backlashconf 45%
  5. 2026-07-01 → 2027-06-30pendingPharma industry lobbying for FDA leadership change escalates publicly
    How: PhRMA, BIO, or top-5 pharma CEO publicly calls for FDA leadership change or reorganization in earnings call, op-ed, or filing
    Source: post-event industry cascadeconf 30%

What if this resolves?

Clamp this prediction TRUE or FALSE and run a counterfactual Gibbs sample. Surfaces the predictions whose marginals shift most under that assumption.
(live posterior: 35%)

Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"

Evidence chain

Every probability update with full Bayesian provenance — chronological, latest first
metadata_milestone_miss_sweep2026-06-04T22:12:05Z34.9%+0.7pp
metadata_milestone_miss_sweep bayesian_v2 n=2 inside=0.290 blend=0.349 LLR=-0.239 κ=0.84 w_in=0.39 fda_breakthrough_label
Raw metadata
{
  "trf": 0.8646529159546616,
  "kappa": 0.8438,
  "base_rate": 0.39,
  "predictor": "Alex Wissner-Gross",
  "total_llr": -0.8109302162163288,
  "grace_days": 7,
  "bayesian_v2": true,
  "prior_logit": -0.6546186743061896,
  "bayes_factor": "1.3:1 against",
  "blend_reason": "blend 39% inside / 60% outside (TRF=0.865, base_rate=0.390 from fda_breakthrough_label)",
  "inside_prior": 0.34194948570078154,
  "kappa_source": "predictor_table",
  "n_milestones": 2,
  "blend_applied": true,
  "contributions": [
    {
      "llr": -0.4054651081081644,
      "kind": "llm_pre_event",
      "kappa": 0.16876000000000002,
      "label": "FDA Commissioner Makary departure, replacement, or announced leave",
      "weight": 0.4,
      "strength": "weak",
      "confidence": 0.2,
      "source_url": "https://www.biopharmadive.com/news/fda-after-turbulent-year-leaves-drugmakers-guessing-on-its-direction/815482/",
      "adjusted_llr": -0.06842629164433384,
      "expected_date": "2026-05-27",
      "measurement_criterion": "HHS or White House announces resignation, removal, or extended leave of FDA Commissioner Marty Makary"
    },
    {
      "llr": -0.4054651081081644,
      "kind": "llm_pre_event",
      "kappa": 0.4219,
      "label": "RFK Jr override of FDA decision becomes public or formal",
      "weight": 0.4,
      "strength": "weak",
      "confidence": 0.5,
      "source_url": "https://www.bostonglobe.com/2026/04/23/newsletters/biotech-rfk-fda-drug-approvals/",
      "adjusted_llr": -0.17106572911083456,
      "expected_date": "2026-05-27",
      "measurement_criterion": "HHS Secretary Kennedy publicly reverses or directs FDA decision in writing, contradicting Makary public stance"
    }
  ],
  "evidence_kind": "metadata_milestone_miss_sweep",
  "inside_source": "history_v2",
  "inside_weight": 0.3947429588317368,
  "outside_weight": 0.6052570411682632,
  "posterior_prob": 0.3489443267506783,
  "posterior_logit": -0.894110695061358,
  "predictor_brier": 0.03413,
  "inside_posterior": 0.2902622532675743,
  "blended_posterior": 0.3489443267506783,
  "reference_class_id": "fda_breakthrough_label",
  "total_adjusted_llr": -0.2394920207551684,
  "predictor_n_resolved": 11
}
LBP2026-05-10T02:00:02Z34.2%-1.0pp
Network propagation: 35.2% → 34.2%
6-iter LBP, residual 0.00584 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run e5c18d29
LBP2026-05-03T02:00:01Z35.2%-1.6pp
Network propagation: 36.8% → 35.2%
6-iter LBP, residual 0.00677 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run 1a683ac9
LBP2026-04-30T16:39:51Z36.8%-2.5pp
Network propagation: 39.3% → 36.8%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v2 · run 0c8a4ea3
legacy v12026-04-30T16:13:50Z39.3%+2.1pp
reference_class_assigned bayesian_v2 inside=0.400 blend=0.393 w_in=0.30 fda_breakthrough_label
LBP2026-04-30T02:18:57Z37.2%-2.1pp
Network propagation: 39.3% → 37.2%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v1 · run 592311ef
legacy v12026-04-30T01:56:50Z39.3%-0.7pp
reference_class_assigned bayesian_v2 inside=0.400 blend=0.393 w_in=0.30 fda_breakthrough_label

Network propagation neighbors

Top edges sorted by latest LBP cross-impact
All propagation →

Top incoming (parents)

Edges that influence THIS node's belief

KindNodeTheir probP(c|s=T)P(c|s=F)Δ implied
prereq234_012
Anthropic revenue will cross OpenAI revenue in middle of 202Peter Diamandis
67.1%0.4000.050-0.066
prereqSEM_042
2025 will be the definitive year that agentic systems finallKevin Weil
73.8%0.4000.050-0.044
prereqSEM_012
Nvidia quadrupled chip production output while only doublingJensen Huang
75.0%0.4000.050-0.039
prereqSEM_008
Training runs costing $10 billion for a single model will coDario Amodei
76.9%0.4000.050-0.033
prereq238_009
Recursive self-improvement is already happening now (no longAlex Wissner-Gross
78.1%0.4000.050-0.029

Top outgoing (children)

Predictions THIS node influences

KindNodeTheir probP(c|s=T)P(c|s=F)Δ implied
prereq231_013
Math is cooked (will be solved), physics cooked, biology chaAlex Wissner-Gross
35.4%0.6200.050-0.111
prereq241_043
ASI will arrive within 2 years to 5 years to this next decadPeter Diamandis
35.9%0.6500.050-0.105
prereq235_030
Ray Kurzweil predicts Longevity Escape Velocity (LEV) by 203Ray Kurzweil
39.2%0.7500.050-0.105
prereqCMQ_002
By 2028, AI systems will reach 'independent researcher' leveSam Altman
31.4%0.5500.050-0.094
prereq232_055
We're exiting the industrial age permanently as recursive sePeter Diamandis
35.5%0.7000.050-0.084

Ticker exposure

34 ticker(s) linked

Beneficiaries (23)

SOUNCRWVSITMNVDAARMGTLBBBAITSMAPLDCEVAAIMSFTMRVLSFTBYORCLQCOMAVGOBABAAMDGOOGLIBMAMZNMETA

Adverse (6)

WNSCHGGCTSHIBMINFYACN

Prerequisites (8)

Predictions that must hit first
TypePredTitleDomainLag
prereqSEM_008Training runs costing $10 billion for a single model will commence sometime in 2025.AI
prereq238_009Recursive self-improvement is already happening now (no longer three years out)AI
prereq234_012Anthropic revenue will cross OpenAI revenue in middle of 2026Markets/Stocks
prereqSEM_012Nvidia quadrupled chip production output while only doubling human headcount — achieved by deploying AI coding tools (Cursor, Claude Code) across engineering.AI/Manufacturing
prereqSEM_0422025 will be the definitive year that agentic systems finally hit the mainstream.AI/Agents
killerTK14Superbubble Pop (S&P 500 -40%, Moonshot Capital Evaporates)
killerTK01AGI Capability Plateau (2026-27 Training Stall)
killerTK03AI Regulatory Moratorium (EU/US Capability Freeze)

Dependents (5)

Predictions enabled by this
TypePredTitleDomainLag
prereq235_030Ray Kurzweil predicts Longevity Escape Velocity (LEV) by 2033.Biotech/Longevity
prereq232_055We're exiting the industrial age permanently as recursive self-improvement unfolds.AI
prereq241_043ASI will arrive within 2 years to 5 years to this next decadeAI
prereq231_013Math is cooked (will be solved), physics cooked, biology char broiled.AI
prereqCMQ_002By 2028, AI systems will reach 'independent researcher' level — driving autonomous scientific discoveries without human intervention.AI

Linked documents (10)

Auto-generated by cosine similarity from Polymarket / Manifold / EDGAR / GDELT
SimSourceTitleMarket probPolarityReviewedPublished
0.583fdaFDA ANDA213267: THALIDOMIDE (THALIDOMIDE) — NATCOmentionspending2026-04-24
0.575fdaFDA ANDA219072: CARBAMAZEPINE (CARBAMAZEPINE) — YICHANG HUMANWELLmentionspending2026-04-17
0.565fdaFDA ANDA209956: POMALIDOMIDE (POMALIDOMIDE) — TEVA PHARMS USAmentionspending2026-04-27
0.563fdaFDA ANDA205571: CARBAMAZEPINE (CARBAMAZEPINE) — ZYDUS PHARMSmentionspending2026-04-29
0.561fdaFDA ANDA211417: LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM) — MACLEODS PHARMS LTDmentionspending2026-05-15
0.560polymarketMiguel Díaz-Canel out as leader of Cuba by December 31?60%mentionspending2026-01-05
0.560fdaFDA NDA018569: FUROSEMIDE (FUROSEMIDE) — EPIC PHARMA LLCmentionspending2026-06-02
0.560polymarketMiguel Díaz-Canel out as leader of Cuba by June 30?12%mentionspending2026-01-04
0.554polymarketIran coup attempt by June 30?4%mentionspending2026-01-06
0.550codex_research_packFDA - Framework for AI Models Used for Drug and Biological Product Submissionsmentionspending2025-01-06

Raw metadata

From Thesis_Timeline_v1.0_FINAL workbook
{
  "nia": false,
  "url": "https://www.youtube.com/watch?v=LVvleNtllPk",
  "mode": "SPECULATION",
  "role": "Host",
  "context": "until some sort of regime change at the FDA which also is not beyond the realm of reason.",
  "to_year": 2026,
  "verbatim": "we're going to see this type of story I think more and more frequently until some sort of regime change at the FDA which also is not beyond the realm of reason.",
  "conv_cues": "not beyond the realm of reason",
  "direction": "HAPPEN",
  "from_year": 2026,
  "timeframe": "future",
  "conv_level": "LOW",
  "milestones": [
    {
      "kind": "prereq",
      "label": "Nvidia quadrupled chip production output while only doubling human headcount — achieved by deploying AI coding tools (Cursor, Claude Code) a",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -7,
      "source_id": "SEM_012",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "prereq",
      "label": "Training runs costing $10 billion for a single model will commence sometime in 2025.",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -6,
      "source_id": "SEM_008",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "prereq",
      "label": "Anthropic revenue will cross OpenAI revenue in middle of 2026",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -5,
      "source_id": "234_012",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "prereq",
      "label": "2025 will be the definitive year that agentic systems finally hit the mainstream.",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -4,
      "source_id": "SEM_042",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "prereq",
      "label": "Recursive self-improvement is already happening now (no longer three years out)",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -3,
      "source_id": "238_009",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "llm_pre_event",
      "label": "FDA Commissioner Makary departure, replacement, or announced leave",
      "source": "BioPharma Dive turnover reporting; InsideHealthPolicy",
      "status": "overdue",
      "weight": 0.4,
      "ordinal": -2,
      "source_id": null,
      "confidence": 0.2,
      "source_url": "https://www.biopharmadive.com/news/fda-after-turbulent-year-leaves-drugmakers-guessing-on-its-direction/815482/",
      "expected_date": "2026-05-27",
      "miss_emitted_at": "2026-06-04T22:12:05.653784+00:00",
      "miss_emitted_by": "metadata_milestone_sweep",
      "research_origin": "training",
      "expected_date_range": {
        "to": "2026-06-22",
        "from": "2026-05-01"
      },
      "measurement_criterion": "HHS or White House announces resignation, removal, or extended leave of FDA Commissioner Marty Makary"
    },
    {
      "kind": "llm_pre_event",
      "label": "RFK Jr override of FDA decision becomes public or formal",
      "source": "BioSpace; Boston Globe Apr 23 2026",
      "status": "overdue",
      "weight": 0.4,
      "ordinal": -1,
      "source_id": null,
      "confidence": 0.5,
      "source_url": "https://www.bostonglobe.com/2026/04/23/newsletters/biotech-rfk-fda-drug-approvals/",
      "expected_date": "2026-05-27",
      "miss_emitted_at": "2026-06-04T22:12:05.653784+00:00",
      "miss_emitted_by": "metadata_milestone_sweep",
      "research_origin": "training",
      "expected_date_range": {
        "to": "2026-06-22",
        "from": "2026-05-01"
      },
      "measurement_criterion": "HHS Secretary Kennedy publicly reverses or directs FDA decision in writing, contradicting Makary public stance"
    },
    {
      "kind": "event",
      "label": "Regime change at the FDA is not beyond the realm of reason.",
      "status": "pending",
      "weight": 1
... (truncated)